Latest Announcements

Ashok Leyland Ltd has scheduled a Board of Directors meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Star Paper Mills Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the unaudited financial results for the quarter ended 30/06/2026.

Octal Credit Capital Ltd has scheduled a board meeting on 12th August 2026 to consider and adopt unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.

Zuari Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2026.

Kaya Ltd's board meeting outcome: approved financial results for Q2 2026, appointed new company secretary, compliance officer, and senior management personnel, and deferred equity issuance plans.

Priya Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the Un-Audited Financial Results for the quarter ended on 30/06/2026.

Kansai Nerolac Paints Ltd's Board of Directors approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and the company's management is responsible for the preparation of the statement in accordance with Indian Accounting Standard 34.

IL&FS Engineering and Construction Company Ltd has published unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, in compliance with SEBI regulations.

Siemens Energy India Ltd will hold a Board meeting on August 6, 2026, to consider the unaudited financial results for the third quarter and nine months ended June 30, 2026.

GlaxoSmithKline Pharmaceuticals Ltd has announced its Q1 FY27 results, with revenue growing 15% YoY to ₹924cr, EBITDA margin expanding 50bps to 31.7%, and PAT margin increasing 200bps to 27.6%. The company's key brands maintained their competitive performance in the market, with Gen Meds and Vx portfolios leading the growth.

Kimia Biosciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 10/08/2026 to consider and approve Un-Audited Financial Results for the first quarter ended on June 30th, 2026.

Tata Chemicals Ltd has announced its Q1FY27 earnings, with a significant accounting change to align its segment reporting with its business operations. The company has renamed its segments to Living, Industry, and Farm Essentials, with Farm Essentials comprising Rallis and Morocco. The company has highlighted stable demand in Living Essentials, particularly in food, feed, and pharma, and a challenging near-term outlook for Industrial Essentials due to global oversupply and cost pressures.

Dolfin Rubbers Ltd has scheduled a board meeting on 11/08/2026 to consider and approve the unaudited financial results for the quarter ended 30th June, 2026.

Computer Age Management Services Ltd (CAMS) has announced its Q1 FY'27 financial results, with a 17.3% Y-o-Y growth in profit after tax (PAT) to ₹128 Cr. and a 46.4% EBITDA margin. CAMS recommends an interim dividend of ₹2.50/- per share.

Mazagon Dock Shipbuilders Ltd has informed the Exchange about Newspaper Advertisement regarding Unaudited Financial Results for the quarter ended 30 June 2026.

Utkarsh Small Finance Bank Ltd has published unaudited financial results for the quarter ended June 30, 2026, in newspapers and on its website, as per Regulation 47 of the SEBI Listing Regulations.

Cosmo First Ltd has scheduled an analyst/investor meet on August 07, 2026, to discuss Q1 FY27 earnings.

Jenburkt Pharmaceuticals Ltd has announced the notice of its 41st Annual General Meeting (AGM) to be held on September 4, 2026, through video conferencing. The meeting will consider various resolutions, including the adoption of audited financial statements, dividend declaration, and reappointment of the Whole Time Director and CFO.

Shanmuga Hospital Ltd has scheduled a board meeting on August 11, 2026, to consider and approve unaudited financial results for Q1 ended June 30, 2026, and to consider and approve the Employee Stock Option Plan 2026.

PCS Technology Ltd has scheduled a board meeting on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The trading window for dealing in securities of the company will remain closed until 48 hours after the financial results are declared.